Abstract Number: 158 • 2017 ACR/ARHP Annual Meeting
Is Lu Eight-Brocades Exercise Beneficial for Patients with Fibromyalgia?
Background/Purpose: Fibromyalgia is a chronic debilitating musculoskeletal pain syndrome that causes substantial physical and psychological impairments. With the release of the 2016 revised EULAR recommendations…Abstract Number: 1991 • 2017 ACR/ARHP Annual Meeting
Fibromyalgia in Russian Refugees: Translation and Validation of the Revised Symptom Impact Questionnaire
Background/Purpose: The Revised Symptom Impact Questionnaire (SIQR) is an updated version of the Revised Fibromyalgia Impact Questionnaire (FIQR) that can be used in both fibromyalgia…Abstract Number: 160 • 2017 ACR/ARHP Annual Meeting
Fibromyalgia Screening Form in the Diagnosis of Concomitant Fibromyalgia
Background/Purpose: We have found that patients with a variety of rheumatic diseases who have concomitant fibromyalgia more frequently fail therapies for the underlying inflammatory rheumatic…Abstract Number: 2115 • 2017 ACR/ARHP Annual Meeting
Mast Cell Activation Features in Ehlers-Danlos/Joint Hypermobility Patients: A Retrospective Analysis in Light of an Emerging Disease Cluster
Background/Purpose: Mast cells are immune cells often residing in connective tissue, best known for their role in allergic and anaphylactic responses1. Mast cell activation syndrome…Abstract Number: 843 • 2017 ACR/ARHP Annual Meeting
The Role of Personality in Patients with Fibromyalgia
Background/Purpose: Previous studies investigating the potential associations between personality and clinical symptoms in fibromyalgia (FM) patients have found mixed results. The purpose of this study…Abstract Number: 2247 • 2017 ACR/ARHP Annual Meeting
Secondary Fibromyalgia Is Not Associated with Higher Likelihood of Patient-Physician Discordance in Global Assessment in Patients with Osteoarthritis and Rheumatoid Arthritis
Background/Purpose: Pain is the strongest driver of patient-physician discordance in global assessment in patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Having secondary fibromyalgia (FM),…Abstract Number: 1058 • 2016 ACR/ARHP Annual Meeting
Adjustment Profiles Comprising Objective and Subjective Measures in Fibromyalgia Patients
Background/Purpose: Only one-third of FM patients obtain benefits after receiving one of the available therapy modalities. Insights into the heterogeneous picture of FM might improve…Abstract Number: 1411 • 2016 ACR/ARHP Annual Meeting
An Electronic MDHAQ (multidimensional health assessment questionnaire) Beyond an Electronic RAPID (routine assessment of patient index data): 21.3% of Rheumatoid Arthritis Patients Identified As Having Secondary Fibromyalgia Versus 3.5% By Clinicians
Background/Purpose: A major impediment to use of patient questionnaires in routine clinical care has been the absence of electronic entry for patients and for doctors…Abstract Number: 1767 • 2016 ACR/ARHP Annual Meeting
Poor Body Image in Lupus: Is It Disease Activity, Damage, Sleep, Pain, Fatigue, Stress, Function, Medications, Depression or Fibromyalgia?
Background/Purpose: Patients with systemic lupus erythematosus (SLE) have poorer body image (BI) than age matched controls. Few studies have been done looking at the effect…Abstract Number: 1791 • 2016 ACR/ARHP Annual Meeting
Loss of Elbow Hyperextension in Females with Early Rheumatologic Disease Was Common in Systemic Lupus Erythematosus and Rheumatoid Arthritis but Rare in Fibromyalgia
Background/Purpose: The elbow extension angle (ELB) is commonly given as 180o although most healthy females exhibit hyperextension(1). The loss of hyperextension (LOH) in a…Abstract Number: 2080 • 2016 ACR/ARHP Annual Meeting
Three Simple Tests to Raise the Index of Suspicion for Fibromyalgia in Primary Care
Background/Purpose: 356 patients were studied (mean age 50 ± 16.3 years, 70% female). Chart review revealed that 53 (15%) of these patients carried a…Abstract Number: 52 • 2016 ACR/ARHP Annual Meeting
Pregabalin Dose-Response for Sleep Quality and Pain Response in Fibromyalgia: A Post-Hoc Analysis of Three Randomized Trials
Background/Purpose: Pregabalin is often administered for treatment of fibromyalgia (FM) at daily doses lower than approved by the US Food and Drug Administration (starting dose…Abstract Number: 33 • 2016 ACR/ARHP Annual Meeting
Prevalence of Growth Hormone Deficiency in Fibromyalgia Patients
Background/Purpose: Low levels of Insulin-dependent growth factor 1 (IGF-1) have been described in Fibromyalgia (FM) patients, suggesting that they have adult growth hormone (GH) deficiency.…Abstract Number: 2200 • 2016 ACR/ARHP Annual Meeting
Association of Active Commuting and Physical Activity in Women with Fibromyalgia
Background/Purpose: Fibromyalgia symptomatology results in a low functional capacity1, limiting the daily activities and the quality of life of the patients2. Walking for commuting is…Abstract Number: 54 • 2016 ACR/ARHP Annual Meeting
Patients with Fibromyalgia in General Have Higher Self-Report Questionnaire Scores Than Patients with Rheumatoid Arthritis: Implications for Clinical Trials and Clinical Research
Background/Purpose: Patients with rheumatoid arthritis (RA) who are included in clinical trials generally are selected for measures indicating high disease activity, such as more than…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 25
- Next Page »